IRRAS Announces Issuance of New Patent for Core IRRAflow® Technology
Stockholm, August 1, 2019 – IRRAS AB (Nasdaq First North Premier: IRRAS), a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced the issuance of United States (U.S.) Patent No. 10,293,105 for its “Fluid Exchange Catheter System” technology upon which the company’s lead IRRAflow technology is based.The patent includes both system and method claims for performing fluid exchange with a catheter that uses aspiration and irrigation lumens and a synchronized pattern of negative and positive pressures to remove any blockages in